Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Malignant Melanoma: Contemporary Management
EP. 1: Management of Stage III Melanoma
June 28th 2019
EP. 2: Molecular Testing for Stage III Melanoma
June 28th 2019
EP. 3: Stage III Melanoma: Adjuvant Therapy Trials
June 28th 2019
EP. 4: Stage III Melanoma: Personalized Management
June 28th 2019
EP. 5: Stage III Melanoma: Changes to Staging System
June 28th 2019
EP. 6: Stage III Melanoma: Neoadjuvant Therapy
June 28th 2019
EP. 7: Pooled Analysis of Neoadjuvant Therapy
June 28th 2019
EP. 8: Progression on Adjuvant Therapy
June 28th 2019
EP. 9: Frontline Therapy in Melanoma
June 28th 2019
EP. 10: Clinical Trials for Frontline Therapy in Melanoma
June 28th 2019
EP. 11: BRAF/MEK Inhibitors in Metastatic Melanoma
June 28th 2019
EP. 12: Metastatic Melanoma Brain Metastases
June 28th 2019
EP. 13: Intralesional Therapy for Metastatic Melanoma
June 28th 2019
EP. 14: Melanoma: Progression After Immunotherapy
June 28th 2019
EP. 15: Novel Agents for the Treatment of Melanoma
June 28th 2019
EP. 16: Future of Treating Melanoma
June 28th 2019
EP. 17: The Role of BRAF Mutations in Melanoma
June 28th 2019
EP. 18: Combination Therapy in Mutated Melanoma
June 28th 2019
EP. 19: Management of Patients with BRAF-Mutated Melanoma
June 28th 2019
EP. 20: The Use of Dual Targeted Therapy in Metastatic Melanoma
June 28th 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x
